Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 3 ( May-June, 2019 ) > List of Articles

Original Article

An Analysis of Large Volume Blood and Blood Product Transfusion in Critically Ill Obstetric Patients: A Retrospective Study

Rumi Bhattacharjee, Nitin Raithatha, Shilpa Sapre, Smruti B Vaishnav, Vishal Sheth

Keywords : Massive blood transfusion, Maternal mortality, Postpartum hemorrhage, Severe obstetric hemorrhage

Citation Information : Bhattacharjee R, Raithatha N, Sapre S, Vaishnav SB, Sheth V. An Analysis of Large Volume Blood and Blood Product Transfusion in Critically Ill Obstetric Patients: A Retrospective Study. J South Asian Feder Obs Gynae 2019; 11 (3):148-152.

DOI: 10.5005/jp-journals-10006-1670

License: CC BY-NC 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Objectives: (1) To study the clinical profile of patients requiring massive blood transfusion (≥4 units). (2) To study the pattern of component requirement in these patients. (3) To study the maternal and fetal outcome. Materials and methods: Design: It is a retrospective database analysis over 2.5 years from January 2014 to June 2017. Setting: Rural tertiary care center in Anand, Gujarat, India. Population/sample: Cases with severe obstetric hemorrhage requiring acute transfusion ≥4 units were included. Samples size is 69. Data were obtained from the medical record department. Parameters analyzed were demographic and obstetric profile, transfusion and laboratory data, adverse maternal and neonatal outcome, data pertaining to intensive care unit (ICU), critical surgical intervention, and complications. Statistical analysis was done using Stata 14. Results: Of total 2619 institutional deliveries and 185 postpartum women referred from outside in the study period, 69 patients required large volume blood transfusion (2.4%). 95% were referred from the government and private setups. Postpartum hemorrhage (PPH) was the leading cause of hemorrhage with high case fatality index and maximum blood product consumption. p value = 0.0033 (nonparametric test). 76.8% required ICU admission and 40.5% required ventilatory support. 23% underwent peripartum hysterectomy. Maternal mortality occurred in 10% patients. Conclusion: Major blood loss in obstetric practice is the leading cause of maternal morbidity and mortality. Improper transfusion practices contribute to a lot of avoidable complications. Rapid recognition of anticipated and unanticipated hemorrhage, early aggressive hemostatic resuscitation, and multidisciplinary intervention can ensure optimal fetomaternal outcome.


HTML PDF Share
  1. Millison PI, Engelfrei CP, et al. Transfussion in Oligaemia: Blood in Clinical Medicine, 10th. ed; 1997.
  2. Fakhry SM, Sheldon GF, et al. Massive transfusion in the surgical patient: American Association of Blood Bank 1994; 135–156.
  3. Balasudha K, Panicker S. Massive obstetric haemorrage: Our experience. International Journal of Reproduction, Contraception, Obstetrics And Gynaecology 2014 March;3(1):40–43.
  4. Say L, Chou D, et al. Tuncalp Leontine Alkema, et al, Global causes of maternal death: a WHO systematic analysis. Lancet Global Health June 2014;2(6):e323–e333. DOI: 10.1016/S2214-109X(14)70227-X.
  5. The Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the anaesthetists: management of massive haemorrhage. Anaesthesia 2010;65:1153–1161. DOI: 10.1111/j.1365-2044.2010.06538.x.
  6. Brohi K, Cohen MJ, et al. Acute coagulopathy of trauma: mechanism identification and effect. Curr Opin Crit care 2007;13:680–685. DOI: 10.1097/MCC.0b013e3282f1e78f.
  7. World Health Organization. Reducing the global burden: postpartum haemorrhage, Making Pregnancy Safer (A newsletter of worldwide activity), 2008, http://www.who.int/making_pregnancy_safer/en. Accesed on 20 May 2017.
  8. Alkema L, Chou D, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030; a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet 2016;387(10017):462–474. DOI: 10.1016/S0140-6736(15)00838-7.
  9. WHO, UNICEF, UNFPA and the World Bank & United Nations Population Division, Trends in Maternal Mortality: 1991 to 2015, WHO, Geneva. The Lancet, Nov 12, 2015. DOI: 10.1016/s0140-6736(15)00838.
  10. Millenium Development Goals: India Country Report 2015.
  11. Register General Of India, Sample Registration System (RGI-SRS). Maternal mortality in India: 1997–2003 trends, causes and risk factors. (2001–2003). Oct 2006, ch. 4. pp. 16–18.
  12. Royal College of Obstetricians and Gynaecologist. Prevention and Management of Postpartum Haemorrhage RCOG Green-top Guideline. 2011;52:1–24.
  13. Gungor T, Simsek A, et al. Surgical treatment of Intractable postpartum haemorrhage and changing trends in modern Obstetrics perspective. Arch Gynacol Obstet 2009;280:351–355. DOI: 10.1007/s00404-008-0914-y.
  14. Glassford NJ, Belloma R. Acute kidney injury: how can we facilitate recovery? Curr Opin Crit Care 2011;17:562–568. DOI: 10.1097/MCC.0b013e32834cd334.
  15. Ickx BE. fluid and blood transfusion in obstetrics. Eur J Anaesthesiol 2010;27:1031–1035. DOI: 10.1097/EJA.0b013e32833c30e3.
  16. Charbit B, Mandelbrot L, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266–273. DOI: 10.1111/j.1538-7836.2007.02297.x.
  17. Kashuk JL, Moore EE, et al. Post injury threatening coagulopathy: Is 1:1 fresh frozen plasma: packed red blood cells the answer? J Trauma 2008 Aug;65(2):261–270. DOI: 10.1097/TA.0b013e31817de3e1.
  18. Riskin DJ, Tsai TC, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality review. Am Coll Surg 2009;209:198–205. DOI: 10.1016/j.jamcollsurg.2009. 04.016.
  19. Snyder CW, Weinberg JA, et al. The relationship of blood product ratio to mortality: Survival benefit or survival bias? J Trauma 2009;66: 358–362. DOI: 10.1097/TA.0b013e318196c3ac.
  20. Patil V, Shetnahajan M. Massive transfusion and massive transfusion protocol. Indian J Anaesth 2014, Sep–Oct;58(5):590–595. DOI: 10.4103/0019-5049.144662.
  21. Raymer JM, Flynn LM, et al. Massive transfusion of blood in the surgical patient. Surg Clin North Am 2012;92:221–234. DOI: 10.1016/j.suc.2012.01.008.
  22. Chidester SJ, Williams N, et al. A pediatric massive transfusion protocol. J Trauna Acute Care Surg 2012;73:1273–1277. DOI: 10.1097/TA.0b013e318265d267.
  23. Roberts I, Shakur H, et al. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096–1101. DOI: 10.1016/S0140-6736(11)60278-X.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.